Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF OPTION ACTIVITY (Details)

v3.21.1
SUMMARY OF OPTION ACTIVITY (Details)
3 Months Ended
Mar. 31, 2021
USD ($)
$ / shares
shares
Share-based Payment Arrangement [Abstract]  
Shares, Outstanding, Beginning balance | shares 14,289,643
Weighted Average Exercise Price, Outstanding, Beginning balance | $ / shares $ 5.15
Shares, Granted | shares 5,996,800
Weighted Average Exercise Price, Granted | $ / shares $ 2.58
Shares, Exercised | shares (788,600)
Weighted Average Exercise Price, Exercised | $ / shares $ 1.13
Shares, Forfeited | shares (1,069,648)
Weighted Average Exercise Price, Forfeited | $ / shares $ 5.57
Shares, Outstanding, Ending balance | shares 18,428,195
Weighted Average Exercise Price, Outstanding, Ending balance | $ / shares $ 4.46
Weighted Average Remaining Contractual Term in Years, Outstanding 7 years 5 months 23 days
Average Intrinsic Value, Outstanding | $ $ 2,841,774
Shares, Vested | shares 9,412,878
Weighted Average Exercise Price, Vested | $ / shares $ 5.16
Weighted Average Remaining Contractual Term in Years, Vested 5 years 8 months 4 days
Average Intrinsic Value, Vested | $ $ 2,758,524
Shares, Vested and expected to vest | shares 17,222,580
Weighted Average Exercise Price, Vested and expected to vest | $ / shares $ 4.56
Weighted Average Remaining Contractual Term in Years, Vested and expected to vest 7 years 3 months 29 days
Aggregate Intrinsic Value, Vested and expected to vest | $ $ 2,830,060